Abstract
A new series of 5-(1-benzyl-1H-1,2,3-triazol-4-yl)-4-methyl-2-arylthiazole derivatives, 6a−w have been synthesized by click reaction of substituted benzylazide, 5a−d with 5-ethynyl-4-methyl-2-substituted phenylthiazole, 4a−f. The starting compounds 4-ethynyl-2-substituted phenylthiazole (4a−f) were synthesized from the corresponding thiazole aldehyde by using the Ohira−Bestmann reagent. The structure of the synthesized compounds was determined by spectral analysis. All the synthesized compounds were screened for their preliminary antitubercular activity against Mycobacterium tuberculosis H37Ra (MTB, ATCC 25177). Most of the synthesized compounds reported good activity against M. tuberculosis H37Ra strain with IC50 range of 0.58−8.23 µg/mL. Compounds 6g and 6k reported good antitubercular activity with MIC90 values of 4.71 and 2.22 µg/mL, respectively. Potential antimycobacterial activity suggested that these compounds could serve as good lead compounds for further optimization and development of a newer antitubercular candidate.
Similar content being viewed by others
References
Abhale YK, Sasane AV, Chavan AP, Deshmukh KK, Kotapalli SS, Ummanni R, Sayyad SF, Mhaske PC (2015) Synthesis and biological screening of 20-aryl/benzyl-2-aryl-4-methyl-4,5-bithiazolyls as possible anti-tubercular and antimicrobial agents. Eur J Med Chem 94:340
Abhale YK, Deshmukh KK, Sasane AV, Chavan AP, Mhaske PC (2016) Synthesis and antitubercular activity of novel 6-substituted-2-(4-methyl-2-substituted phenylthiazol-5-yl)H-imidazo[1,2-a]pyridine. J Heterocycl Chem 53:229
Abhale YK, Sasane AV, Chavan AP, Shekh SH, Deshmukh KK, Bhansali S, Nawale L, Sarkar D, Mhaske PC (2017) Synthesis and antimycobacterial screening of new thiazolyl-oxazole derivatives. Eur J Med Chem 132:333
Alley MC, Scudiere DA, Monks A, Hursey ML, Czerwinski MJ, Fine DL, Abbott BJ, Mayo JG, Shoemaker RH, Boyd MR (1988) Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. Cancer Res 48(3):589–601
Azzali E, Machado D, Kaushik A, Vacondio F, Flisi S, Cabassi C, Lamichhane G, Viveiros M, Costantino G, Pieroni M (2017) Substituted N-phenyl-5-(2-(phenylamino)thiazol-4-yl)isoxazole-3-carboxamides are valuable antitubercular candidates that evade innate efflux machinery. J Med Chem 60:7108
Bansode P, Jadhav J, Kurane R, Choudhari P, Bhatia M, Khanapure S, Salunkhe R, Rashinkar G (2016) Potentially antibreast cancer enamidines via azide– alkyne–amine coupling and their molecular docking studies. RSC Adv 6:90597
Barradas JS, Errea MI, D’Accorso NB, Sepulveda CS, Damonte EB (2011) Imidazo[2,1-b]thiazole carbohydrate derivatives: Synthesis and antiviral activity against Junin virus, agent of Argentine hemorrhagic fever. Eur J Med Chem 46:259–264
Chen MD, Lu SJ, Yuag GP, Yang SY, Du XL (2000) Synthesis and antibacterial activity of some heterocyclic beta-enamino ester derivatives with 1, 2, 3-triazole. Heterocycl Comm 6:421
Christian F, Ben M, Susan Z, Joey M, Hua Z, Colby BW (2008) Preparation of triazole derivatives for treating Alzheimer’s disease and related conditions, WIPO patent, WO2008156580A1
Davyt D, Serra G (2010) Thiazole and oxazole alkaloids: isolation and synthesis. Mar Drugs 8:2755
Dmitry V, Demchuk AV, Samet NB, Chernysheva VI, Ushkarov GA, Stashina LD, Konyushkin MM, Raihstat SI, Firgang AA, Philchenkov MP, Zavelevich LM, Kuiava VF, Chekhun DY, Blokhin AS, Kiselyov MN, Semenova VV (2014) Synthesis and antiproliferative activity of conformationally restricted 1,2,3-triazole analogues of combretastatins in the sea urchin embryo model and against human cancer cell lines. Bioorg Med Chem 22:738
Dongamanti A, Arram G, Bommidi V, Sidda R, Banoth R (2014) Microwave assisted synthesis and antimicrobial activity of novel 1-[1/2-(1-Benzyl-1H-[1,2,3]triazol-4-ylmethoxy)-naphthalen-2/1-yl]-3-(1-phenyl-3-aryl-1H-pyrazol-4-yl)-propenones. Org Commun 8:24
Farghaly A. R, El-Kashef H (2006) Synthesis of some new azoles with antiviral potential ARKIVOC xi_76
Foks H, Janowiec M, Zwolska Z, Augustynowicz-Kopeć E (2005) Synthesis and tuberculostatic activity of some 2-Piperazinmethylene derivatives 1,2,4-Triazole-3-Thiones. Phosphorus Sulfur Silicon Relat Elem 180:537
Gaikwad ND, Patil SV, Bobade VD (2012a) Synthesis and biological evaluation of some novel thiazole substituted benzotriazole derivatives. Bioorg & Med Chem Lett 22:3449
Gaikwad ND, Patil SV, Bobade VD (2012b) Hybrids of ravuconazole: Synthesis and biological evaluation. Eur J Med Chem 54:295
Giri RS, Thaker HM, Giordano T, Williams J, Rogers D, Sudersanam V, Vasu KK (2009) Synthesis and characterization of novel 2-(2,4-disubstituted-thiazole-5-yl)-3-aryl-3H-quinazoline-4-one derivatives as inhibitors of NF-kB and AP-1 mediated transcription activation and as potential anti-inflammatory agents. Eur J Med Chem 44:2184
Gonzaga DT, da Rocha DR, da Silva FC, Ferreira VF (2013) Recent advances in the synthesis of new antimycobacterial agents based on the 1H-1,2,3-triazoles. Curr Top Med Chem 13:2850
Guan LP, Jin QH, Tian GR, Chai KY, Quan ZS (2007) Synthesis of some quinoline-2(1H)-one and 1,2,4-triazolo [4,3-a]quinoline derivatives as potent anticonvulsants. J Pharm Sci 10:254
Gujjar R, Marwaha A, White J, White L, Creason S, Shackleford DM, Baldwin J, Charman WN, Buckner FS, Charman S, Rathod PK, Phillips MA (2009) Identification of a metabolically stable triazolopyrimidine-based dihydroorotate dehydrogenase inhibitor with antimalarial activity in mice. J Med Chem 52:1864
Güzeldemirci NU, Küçükbasmac Ö (2010) Synthesis and antimicrobial activity evaluation of new 1,2,4-triazoles and 1,3,4-thiadiazoles bearing imidazo[2,1-b]thiazole moiety. Eur J Med Chem 45:63
Hafez HN, Abbas HA, El-Gazzar AR (2008) Synthesis and evaluation of analgesic, anti-inflammatory and ulcerogenic activities of some triazolo- and 2-pyrazolyl-pyrido[2,3-d]-pyrimidines. Acta Pharm 58:359
Holla BS, Mahalinga M, Karthikeyen MS, Poojary B, Akberali PM, Kumari NS (2005) Synthesis, characterization and antimicrobial activity of some substituted 1,2,3-triazoles. Eur J Med Chem 40:1173
Jadhav GR, Shaikh MU, Kale RP, Shiradkar MR, Gill CH (2009) SAR study of clubbed [1,2,4]-triazolyl with fluorobenzimidazoles as antimicrobial and antituberculosis agents. Eur J Med Chem 44:2930
Jeankumar VU, Chandran M, Samala G, Alvala M, Koushik PV, Yogeeswari P, Salina EG, Sriram D (2012) Development of 5-nitrothiazole derivatives: Identification of leads against both replicative and latent Mycobacterium tuberculosis. Bioorg & Med Chem Lett 22:7414
Jeankumar VU, Rudraraju SR, Vats R, Janupally R, Saxena S, Yogeeswari P, Sriram D (2016) Engineering another class of anti-tubercular lead: Hit to lead optimization of an intriguing class of gyrase ATPase inhibitors. Eur J Med Chem 122:216
Jeong K, Lee J, Park S, Choi J, Jeong D, Choi D, Nam Y, Park J, Lee K, Kim S, Ku J (2015) Synthesis and in-vitro evaluation of 2-amino-4-arylthiazole as inhibitor of 3D polymerase against foot-and-mouth disease (FMD). Eur J Med Chem 102:375
iLOGP (2014) a simple, robust, and efficient description of n-octanol/water partition coefficient for drug design using the GB/SA approach. J Chem Inf Model 54:3284
Karale BK, Takate SJ, Salve SP, Zaware BH, Jadhav SS (2014) Synthesis and biological screening of thiazolyl triazoles and thiazoles. Indian J Chem 53B:339
Kashyap SJ, Garg VK, Sharma PK, Kumar N, Dudhe R, Gupta JK (2012) Thiazoles: having diverse biological activities. Med Chem Res 21:2123
Kathiravan MK, Salake A, Chothe AS, Dudhe PB, Watode RP, Mukta MS, Gadhwe S (2012) The biology and chemistry of antifungal agents: a review. Bioorg & Med Chem 20:5678
Keri RS, Patil SA, Budagumpi S, M.Nagaraja B (2015) Triazole: a promising antitubercular agent. Chem Biol Drug Des 86:410
Khan A, Sarkar D (2008) A simple whole cell based high throughput screening protocol using Mycobacterium bovis BCG for inhibitors against dormant and active tubercle bacilli. J Microbiol Methods 73:62
Kouatly O, Geronikaki A, Kamoutsis C, Hadjipavlou-Litina D, Eleftheriou P (2008) Adamantane derivatives of thiazolyl-N-substituted amide, as possible non-steroidal anti-inflammatory agents. Eur J Med Chem 44:1198
Krishna KM, Inturi B, Pujar GV, Purohit MN, Vijaykumar GS (2014) Design, synthesis and 3D-QSAR studies of new diphenylamine containing 1,2,4-triazoles as potential antitubercular agents. Eur J Med Chem 84:516
Li H, He D, Zhao X, Sun T, Zhang Q, Bai C, Chen Y (2018) Design and synthesis of novel dasatinib derivatives as inhibitors of leukemia stem cells. Bio-Org Med Chem Lett 28:700
Liu ZY, Wang YM, Li ZR, Jiang JD, Boykin DW (2009) Synthesis and anticancer activity of novel 3,4-diarylthiazol-2(3H)-ones (imines). Bioorg Med Chem 19:5661
Liu Z, Zhu Q, Li F, Zhang L, Leng Y, Zhang A (2011) N-(5-substituted thiazol-2-yl)-2-aryl-3-(tetrahydro-2H-pyran-4-yl)propanamides as glucokinase activators. Med Chem Commun 2:531
Martinelli LKB, Rotta M, Villela AD, Rodrigues-Junior VS, Abbadi BL, Trindade RV, Petersen GO, Danesi GM, Nery LR, Pauli I, Campos MM, Bonan CD, de Souza ON, Basso LA, Santos DS (2017) Functional, thermodynamics, structural and biological studies of in silico-identified inhibitors of Mycobacterium tuberculosis enoyl-ACP(CoA) reductase enzyme. Sci Rep 7:46696
Mishra CB, Kumari S, Tiwari M (2015) Thiazole: A promising heterocycle for the development of potent CNS active agents. Eur J Med Chem 92:1
Oniga O, Ndongo JT, Moldovan C, Tiperciuc B, Oniga S, Pirnau A, Vlase L, Verite P (2012) Synthesis and antimicrobial activity of some new 2- hydrazone-thiazoline-4-ones. Farmacia 60:6785
Oniga S, Duma M, Oniga O, Tiperciuc B, Pirnau A, Araniciu C, Palage M (2015) Synthesis of some new 4-methyl-2-(4-pyridyl)-thiazole-5-yl-azoles as potential antimicrobial agents. Farmacia 63:2
Pandya DH, Sharma JA, Jalani HB, Pandya AN, Sudarsanam V, Kachler S, NorbertKlotz K, Vasu KK (2015) Novel thiazole–thiophene conjugates as adenosine receptor antagonists: Synthesis, biological evaluation and docking studies. Bioorg & Med Chem Lett 25:1306
Passannanti A, Diana P, Barraja P, Mingooia F, Lauria A, Cirrincine G (1998) Pyrrolo[2,3-d][1,2,3]triazoles as potential antineoplastic agents. Heterocycles 48:1229
Patil KT, Walekar LS, Undare SS, Kolekar GB, Deshmukh MB, Choudhari PB, Anbhule PV (2016) Selective synthesis of 10,11-dihydrochromeno[4,3-b]chromene-6,8(7H,9H)-dione using copper oxide nanoparticles for potential inhibitors of β-ketoacyl-[acyl-carrier-protein]synthase III of Mycobacterium tuberculosis. Indian J Chem Sect B 55B:1151
Patpi SR, Pulipati L, Yogeeswari P, Sriram D, Jain N, Sridhar B, Murthy R, Devi AT, Kalivendi SV, Kantevari S (2012) Design, synthesis, and structure–activity correlations of novel dibenzo[b,d]furan, dibenzo[b,d]thiophene, and N-methylcarbazole clubbed 1,2,3-triazoles as potent inhibitors of Mycobacterium tuberculosis. J Med Chem 55:3911
Patravale AA, Gore AH, Kolekar GB, Deshmukh MB, Choudhari PB, Bhatia MS, Prabhu S, Jamdhade MD, Patole MS, Anbhule PV (2016) Synthesis, biological evaluation and molecular docking studies of some novel indenospiro derivatives as anticancer agents. J Taiwan Inst Chem Eng 68:105
Ramesh R, Shingare RD, Kumar V, Anand A, Swetha B, Veeraraghavan S, Viswanadha S, Ummanni R, Gokhale R, Reddy DS (2016) Repurposing of a drug scaffold: Identification of novel sila analogues of rimonabant as potent antitubercular agents. Eur J Med Chem 122:723
Reddy T, Kulhari H, Reddy V, Rao AVS, Bansal V, Kamal A, Shukla R (2015) Synthesis and biological evaluation of pyrazolo-triazole hybrids as cytotoxic and apoptosis inducing agents. Organic & Biomol Chem 13:10136
Rostom SAF, El-Ashmawy IM, Abd El Razik HA, Badr MH, Ashour HMA (2009) Design and synthesis of some thiazolyl and thiadiazolyl derivatives of antipyrine as potential non-acidic anti-inflammatory, analgesic and antimicrobial agents. Bioorg Med Chem 17:882
Samala G, Devi PB, Saxena S, Meda N, Yogeeswari P, Sriram D (2016) Design, synthesis and biological evaluation of imidazo[2,1-b]thiazole and benzo[d]imidazo[2,1-b]thiazole derivatives as Mycobacterium tuberculosis pantothenate synthetase inhibitors. Bioorg & Med Chem 24:1298
Sarkar S, Sarkar D (2012) Potential use of nitrate reductase as a biomarker for the identification of active and dormant inhibitors of Mycobacterium tuberculosis in a THP1 infection model. J Biomol Screen 17:966
Shaikh MH, Subhedar DD, Nawale L, Sarkar D, Khan FAK, Sangshetti JN, Shingate BB (2015) 1,2,3-Triazole derivatives as antitubercular agents: synthesis, biological evaluation and molecular docking study. Med Chem Comm 6:1104
Shanmugavelan P, Nagarajan S, Sathishkumar M, Ponnuswamy A, Yogeeswari P, Sriram D (2011) Efficient synthesis and in vitro antitubercular activity of 1,2,3-triazoles as inhibitors of Mycobacterium tuberculosis. Bioorg Med Chem Lett 21:7273
Shanthi V, Ramanathan K (2014) Identification of potential inhibitor targeting enoyl-acyl carrier protein reductase (InhA) in Mycobacterium tuberculosis: a computational approach. Biotech 4:253
Shelke SH, Mhaske PC, Nandave M, Narkhade S, Walhekar NM, Bobade VD (2012) Synthesis and pharmacological evaluation of a novel series of 3-aryl-2-(2-substituted-4-methylthiazole-5-yl) thiazolidin-4-one as possible anti-inflammatory and antimicrobial agents. Bioorg Med Chem Lett 22:6373
Shinde V, Mahulikar P, Mhaske PC, Nawale L, Sarkar D (2018) Synthesis and biological evaluation of new 2-aryl-4-((4-aryl-1H-1,2,3-triazol-1-yl)methyl)thiazole derivatives. Res Chem Intermed 44:1247
Shiradkar M, Kumar S, Dasari V, Tatikonda S, Akula KC, Shah R (2007) Clubbed triazoles: a novel approach to antitubercular drugs. Eur J Med Chem 42:807
Shiradkar MR, Murahari KK, Reddy GH, Tatikonda S, Chakravarthy AK, Dolly P, Kaur R, Burange P, Ghogare J, Mokalec V, Rautc M (2007) Synthesis of new S-derivatives of clubbed triazolyl thiazole as anti-Mycobacterium tuberculosis agents. Bioorg Med Chem 15:3997
Shiran JA, Yahyazadeh A, Mamaghani M, Rassa M (2013) Regioselective synthesis of novel 3-allyl-2-(substituted imino)-4-phenyl-3H-thiazole and 2,2′-(1,3-phenylene)bis(3-substituted-2-imino-4-phenyl-3H-thiazole) derivatives as antibacterial agents. J Mol Struct 1039:113
Shenoi S, Friedland G (2009) Extensively drug-resistant tuberculosis: a new face to an old pathogen. Annu Rev Med 60:307
Shirude PS, Madhavapeddi P, Naik M, Murugan K, Shinde V, Nandishaiah R, Bhat J, Kumar A, Hameed S, Holdgate G, Davies G, McMiken H, Hegde N, Ambady A, Venkatraman J, Panda M, Bandodkar B, Sambandamurthy VK, Read JA (2013) Methyl-Thiazoles: a novel mode of inhibition with the potential to develop novel inhibitors targeting InhA in mycobacterium tuberculosis. J Med Chem 56:8533
Singh R, Nawale L, Arkile M, Shedbalkar U, Wadhwani S, Sarkar D, Chopade B (2015) Chemical and biological metal nanoparticles as antimycobacterialagents: a comparative study. Int J Antimicrob Agents 46:183
Skedelj V, Perdih A, Brvar M, Kroflic A, Dubbée V, Savage V, O’Neill AJ, Solmajer T, Bester-Rogac M, Blanot D, Hugonnet JE, Magnet S, Arthur M, Mainardi JL, Stojan J, Zega A (2013) Discovery of the first inhibitors of bacterial enzyme d-aspartate ligase from Enterococcus faecium (Aslfm). Eur J Med Chem 67:208
SwissADME (2017) a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep 7:42717
Tantry SJ, Markad SD, Shinde V, Bhat J, Balakrishnan G, Gupta AK, Ambady A, Raichurkar A, Kedari C, Sharma S, Mudugal NV, Narayan A, Naveen Kumar CN, Nanduri R, Bharath S, Reddy J, Panduga V, Prabhakar KR, Kandaswamy K, Saralaya R, Kaur P, Dinesh N, Guptha S, Rich K, Murray D, Plant H, Preston M, Ashton H, Plant D, Walsh J, Alcock P, Naylor K, Collier M, Whiteaker J, McLaughlin RE, Mallya M, Panda M, Rudrapatna S, Ramachandran V, Shandil R, Sambandamurthy VK, Mdluli K, Cooper CB, Rubin H, Yano T, Iyer P, Narayanan S, Kavanagh S, Mukherjee K, Balasubramanian V, Hosagrahara VP, Solapure S, Ravishankar S, Shahul HP (2017) Discovery of Imidazo[1,2-a]pyridine ethers and squaramides as selective and potent inhibitors of mycobacterial adenosine triphosphate (ATP) synthesis. J Med Chem 60:1379
Tomasic T, Katsamakas S, Hodnik Z, Ilas J, Brvar M, Solmajer T, Montalvao S, Tammela P, Banjanac M, Ergovic G, Anderluh M, Masic LP, Kikelj D (2015) Discovery of 4,5,6,7-Tetrahydrobenzo [1,2-d]thiazoles as novel DNA gyrase inhibitors targeting the ATP-binding site. J Med Chem 58:5501
Wang Q, Song F, Xiao X, Huang P, Li L, Monte A, Abdel-Mageed WM, Wang J, Guo H, He W, Xie F, Dai H, Liu M, Chen C, Xu H, Liu M, Piggott AM, Liu X, Capon RJ, Zhang L (2013) Abyssomicins from the South China Sea deep-sea sediment Verrucosispora sp.: natural thioether Michael addition adducts as antitubercular prodrugs. Angew Chem Int Ed 52:1231
Wang X, Dai Z, Chen Y, Cao L, Yan W, Li S, Wang J, Zhang Z, Ye Y (2017) Synthesis of 1,2,3-triazole hydrazide derivatives exhibiting anti-phytopathogenic activity. Eur J Med Chem 126:171
Weide T, Saldanha SA, Minond D, Spicer TP, Fotsing JR, Spaargaren M, Frere J, Bebrone C, Sharpless KB, Hodder PS, Fokin VV (2010) NH-1,2,3-Triazole inhibitors of the VIM-2 metallo-β-lactamase. ACS Med Chem Lett 1:150
World Health Organization (2016) Tuberculosis Fact Sheet. http://www.who.int/news-room/fact-sheets/detail/tuberculosis.
Acknowledgements
The authors would like to thank CSIR-NCL, Pune for supporting the biological activity. Central Analysis facility, Savitribai Phule Pune University, Pune is also acknowledged for the spectral analysis.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Appendix A
Supplementary data
Supplementary information
Rights and permissions
About this article
Cite this article
Shinde, V., Mahulikar, P., Mhaske, P.C. et al. Synthesis and antimycobacterial evaluation of new 5-(1-benzyl-1H-1,2,3-triazol-4-yl)-4-methyl-2-arylthiazole derivatives. Med Chem Res 28, 805–819 (2019). https://doi.org/10.1007/s00044-019-02310-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00044-019-02310-y